Aug 18, 2006 1:36 pm US/Central
Morning-After Pill Refiled For Over Counter Sale
WASHINGTON (AP) ―
-
-
Barr Pharmaceuticals Inc. amended its application to seek FDA permission for over-the-counter sales of the pills, called Plan B, to women 18 and older.
AP
The manufacturer of the morning-after pill submitted a revised application Friday seeking federal approval to sell the emergency contraceptive without a prescription.
Barr Pharmaceuticals Inc. resubmitted the application to the Food and Drug Administration, company spokeswoman Carol Cox said.
The company amended its application to seek FDA permission for over-the-counter sales of the pills, called Plan B, to women 18 and older. The pills are now sold only by prescription in most states.
"Currently, we remain committed to an expeditious review," FDA spokeswoman Susan Bro said. Bro would not say when the FDA would decide on the amended application.
Barr originally applied to sell the pills to girls and women of all ages, but later amended its application to limit over-the-counter sales to those 16 and older.
The FDA told it last month it would reconsider that application if the company further amended it to limit nonprescription sales to adult women. The agency also wants details on how pharmacists would enforce the age restrictions on those sales.
Plan B contains a high dose of a drug found in many regular birth control pills that, taken within 72 hours of unprotected sex, can lower the risk of pregnancy by up to 89 percent.
(© 2006 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)
Comments